Your browser doesn't support javascript.
loading
Childhood cancer drugs in China: An overview and comparison of regulatory approvals in China and the United States.
Zhang, Yichen; Katharina Wagner, Anita; Du, Haoxin; Han, Taisen; Gupta, Sumit; Denburg, Avram E; Frazier, A Lindsay; Guan, Xiaodong; Shi, Luwen.
Affiliation
  • Zhang Y; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Katharina Wagner A; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Du H; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Han T; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Gupta S; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Denburg AE; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Frazier AL; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Guan X; Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Shi L; Dana-Farber/Boston Children's Cancer and Blood Disorders Centre, Boston, Massachusetts, USA.
Int J Cancer ; 150(3): 482-490, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34536294
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Approval / Neoplasms / Antineoplastic Agents Limits: Child / Humans Country/Region as subject: America do norte / Asia Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Approval / Neoplasms / Antineoplastic Agents Limits: Child / Humans Country/Region as subject: America do norte / Asia Language: En Year: 2022 Type: Article